Benz R, Gisin B F, Ting-Beall H P, Tosteson D C, Läuger P
Biochim Biophys Acta. 1976 Dec 14;455(3):665-84. doi: 10.1016/0005-2736(76)90040-7.
The cyclic dodecapeptide PV, cyclo-(D-Val-L-Pro-L-Val-D-Pro)3, a structural analogue of the ion-carrier valinomycin, increases the cation permeability of lipid bilayer membranes. This paper reports the results of two types of relaxation experiments, namely relaxation of the membrane current after a voltage jump and decay of the membrane voltage after a charge pulse in lipid bilayer membranes exposed to PV. From the relaxation data, the rate constant for the translocation of the ion carrier complex across the membrane, as well as the partition coefficient of the complex between water and membrane solution interface were computed and found to be about one order of magnitude less than the comparable values for valinomycin (Val). Furthermore, the dependence of the initial membrane conductivity on ion concentration was used to evaluate the equilibrium constant, K, of complexation between PV and some monovalent cations in water. The values of K yield the following selectivity sequence of PV: Na+ less than NH4+ less than K+ less than Cs+ less than Rb+. These and earlier results are consistent with the idea that PV promotes cation movement across membranes by the solution complexation mechanism which involves complexation between ion and carrier in the aqueous phase and transport of the carrier across the membrane. In the particular form of the solution complexation mechanism operating here, the PV present in the PV-cation complex carrying charge across the membrane derives from the side from which the current is flowing (cis-mechanism). As shown previously, valinomycin, in contrast to PV, acts by an interfacial complexation mechanism in which the Val in the Val-cation complex derives from the side toward which current is flowing (trans-mechanism). The comparison of the kinetic properties of these two closely related compounds yields interesting insights into the relationship between chemical structure and function of ion carriers.
环状十二肽PV,即环-(D-缬氨酸-L-脯氨酸-L-缬氨酸-D-脯氨酸)3,是离子载体缬氨霉素的结构类似物,可增加脂质双层膜的阳离子通透性。本文报道了两种弛豫实验的结果,即在暴露于PV的脂质双层膜中,电压阶跃后膜电流的弛豫以及电荷脉冲后膜电压的衰减。根据弛豫数据,计算出离子载体复合物跨膜转运的速率常数以及该复合物在水与膜溶液界面之间的分配系数,发现它们比缬氨霉素(Val)的相应值小约一个数量级。此外,利用初始膜电导率对离子浓度的依赖性来评估PV与水中一些单价阳离子络合的平衡常数K。K值得出PV的以下选择性顺序:Na+ < NH4+ < K+ < Cs+ < Rb+。这些结果以及早期的结果与以下观点一致,即PV通过溶液络合机制促进阳离子跨膜移动,该机制涉及离子与载体在水相中的络合以及载体跨膜的转运。在这里起作用的溶液络合机制的特定形式中,携带电荷跨膜的PV-阳离子复合物中的PV来自电流流动的一侧(顺式机制)。如先前所示,与PV相反,缬氨霉素通过界面络合机制起作用,其中Val-阳离子复合物中的Val来自电流流动的一侧(反式机制)。对这两种密切相关化合物的动力学性质进行比较,有助于深入了解离子载体的化学结构与功能之间的关系。